Literature DB >> 26106241

High-grade culprit lesions are a common cause of ST-segment elevation myocardial infarction.

Michael Liang1, Takashi Kajiya1, Mark Y Chan1, Edgar Tay1, Chi-Hang Lee1, Arthur Mark Richards1, Adrian F Low1, Huay Cheem Tan1.   

Abstract

INTRODUCTION: Conventional knowledge holds that the majority of ruptured atherosclerotic plaques causing ST-segment elevation myocardial infarction (STEMI) are found in moderate stenoses that produce < 50% loss of arterial diameter. This study aimed to analyse the culprit lesions in patients who presented with STEMI and underwent primary percutaneous coronary intervention (PPCI) at our institution.
METHODS: Patients who underwent PPCI between June 2008 and August 2010 at our institution were included in the analysis. Quantitative coronary angiography was performed for the culprit lesions immediately after antegrade flow was restored by thrombectomy, low-profile balloon predilatation or guidewire crossing.
RESULTS: A total of 1,021 patients were included in the study. The mean age was 57 ± 12 years and 85.2% were male. Lesion measurement was done after coronary flow was restored by thrombectomy (73.1%), balloon dilatation (24.1%) and following guidewire passage across the lesion (2.8%). Mean minimal luminal diameter was 1.1 ± 0.5 mm, mean reference vessel diameter was 2.8 ± 0.6 mm, mean diameter stenosis was 61 ± 16% and mean lesion length was 16 ± 6 mm. Most (80.2%) of the culprit lesions had diameter stenoses > 50% (p < 0.01). Although balloon angioplasty was performed in 24.1% of the patients, the majority (64.2%) still had diameter stenoses > 50%. High-grade stenoses (> 50%) were more frequently observed in male patients (p = 0.04).
CONCLUSION: Contrary to the existing paradigm, we found that most of the patients with STEMI in our institution had culprit lesions with diameter stenosis > 50%.

Entities:  

Keywords:  acute myocardial infarction; atherosclerosis; coronary artery disease; lesion assessment; percutaneous coronary intervention

Mesh:

Year:  2015        PMID: 26106241      PMCID: PMC4469852          DOI: 10.11622/smedj.2015092

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  20 in total

1.  Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study.

Authors:  Nico H J Pijls; Pepijn van Schaardenburgh; Ganesh Manoharan; Eric Boersma; Jan-Willem Bech; Marcel van't Veer; Frits Bär; Jan Hoorntje; Jacques Koolen; William Wijns; Bernard de Bruyne
Journal:  J Am Coll Cardiol       Date:  2007-05-17       Impact factor: 24.094

2.  The relationship between coronary stenosis severity and compression type coronary artery movement in acute myocardial infarction.

Authors:  Kim H Chan; Chirapan Chawantanpipat; Tim Gattorna; Thamarath Chantadansuwan; Adrienne Kirby; Ann Madden; Anthony Keech; Martin K C Ng
Journal:  Am Heart J       Date:  2010-04       Impact factor: 4.749

3.  Angiographic progression of coronary artery disease and the development of myocardial infarction.

Authors:  J A Ambrose; M A Tannenbaum; D Alexopoulos; C E Hjemdahl-Monsen; J Leavy; M Weiss; S Borrico; R Gorlin; V Fuster
Journal:  J Am Coll Cardiol       Date:  1988-07       Impact factor: 24.094

4.  Angiographic disease progression and residual risk of cardiovascular events while on optimal medical therapy: observations from the COURAGE Trial.

Authors:  G B John Mancini; Pamela M Hartigan; Eric R Bates; Steven P Sedlis; David J Maron; John A Spertus; Daniel S Berman; William J Kostuk; Leslee J Shaw; William S Weintraub; Koon K Teo; Marcin Dada; Bernard R Chaitman; Robert A O'Rourke; William E Boden
Journal:  Circ Cardiovasc Interv       Date:  2011-11-01       Impact factor: 6.546

5.  Considerable time from the onset of plaque rupture and/or thrombi until the onset of acute myocardial infarction in humans: coronary angiographic findings within 1 week before the onset of infarction.

Authors:  S Ojio; H Takatsu; T Tanaka; K Ueno; K Yokoya; T Matsubara; T Suzuki; S Watanabe; N Morita; M Kawasaki; T Nagano; I Nishio; K Sakai; K Nishigaki; G Takemura; T Noda; S Minatoguchi; H Fujiwara
Journal:  Circulation       Date:  2000-10-24       Impact factor: 29.690

6.  Intravascular ultrasound analysis of infarct-related and non-infarct-related arteries in patients who presented with an acute myocardial infarction.

Authors:  Jun-ichi Kotani; Gary S Mintz; Marco T Castagna; Ellen Pinnow; Chalak O Berzingi; Anh B Bui; Augusto D Pichard; Lowell F Satler; William O Suddath; Ron Waksman; John R Laird; Kenneth M Kent; Neil J Weissman
Journal:  Circulation       Date:  2003-06-02       Impact factor: 29.690

7.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction).

Authors:  Elliott M Antman; Daniel T Anbe; Paul Wayne Armstrong; Eric R Bates; Lee A Green; Mary Hand; Judith S Hochman; Harlan M Krumholz; Frederick G Kushner; Gervasio A Lamas; Charles J Mullany; Joseph P Ornato; David L Pearle; Michael A Sloan; Sidney C Smith; Joseph S Alpert; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Gabriel Gregoratos; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs
Journal:  Circulation       Date:  2004-08-03       Impact factor: 29.690

8.  Pre-existing coronary stenoses in patients with first myocardial infarction are not necessarily severe.

Authors:  D Hackett; G Davies; A Maseri
Journal:  Eur Heart J       Date:  1988-12       Impact factor: 29.983

9.  Acute myocardial infarction and underlying stenosis severity.

Authors:  Ole Frøbert; Marcel van't Veer; Wilbert Aarnoudse; Ulf Simonsen; Jacques J Koolen; Nico H J Pijls
Journal:  Catheter Cardiovasc Interv       Date:  2007-12-01       Impact factor: 2.692

Review 10.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

Authors:  Morteza Naghavi; Peter Libby; Erling Falk; S Ward Casscells; Silvio Litovsky; John Rumberger; Juan Jose Badimon; Christodoulos Stefanadis; Pedro Moreno; Gerard Pasterkamp; Zahi Fayad; Peter H Stone; Sergio Waxman; Paolo Raggi; Mohammad Madjid; Alireza Zarrabi; Allen Burke; Chun Yuan; Peter J Fitzgerald; David S Siscovick; Chris L de Korte; Masanori Aikawa; K E Juhani Airaksinen; Gerd Assmann; Christoph R Becker; James H Chesebro; Andrew Farb; Zorina S Galis; Chris Jackson; Ik-Kyung Jang; Wolfgang Koenig; Robert A Lodder; Keith March; Jasenka Demirovic; Mohamad Navab; Silvia G Priori; Mark D Rekhter; Raymond Bahr; Scott M Grundy; Roxana Mehran; Antonio Colombo; Eric Boerwinkle; Christie Ballantyne; William Insull; Robert S Schwartz; Robert Vogel; Patrick W Serruys; Goran K Hansson; David P Faxon; Sanjay Kaul; Helmut Drexler; Philip Greenland; James E Muller; Renu Virmani; Paul M Ridker; Douglas P Zipes; Prediman K Shah; James T Willerson
Journal:  Circulation       Date:  2003-10-07       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.